HHM Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
PR
AAS
WAM
RFM
NHFG
MFS
LRPA
SGH
EWM
HHM Wealth Advisors's XBI Position: Q2 2026 in Review
HHM Wealth Advisors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 50 shares worth $7.91K. The position accounts for ﹤0.01% of the portfolio, ranked #660.
HHM Wealth Advisors first reported a position in XBI in Q2 2020 and has held it in 25 quarters since. The position peaked at $14K in Q2 2021. 293 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- HHM Wealth Advisors held 50 shares of State Street SPDR S&P Biotech ETF worth $7.91K as of Q2 2026.
- HHM Wealth Advisors left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #660 holding.
- HHM Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and has held it in 25 quarters since.
- HHM Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $14K in Q2 2021.
- 293 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.